Lantern Pharma provides disclosure channels reminder; no material news

Lantern Pharma Inc.

Filing details company's website, press releases, SEC filings, newsletters, and social media as information channels.
No financial results, clinical updates, or material events reported.
Company reiterates emerging growth company status and extended transition period election.

item 8.01

Lantern Pharma Inc. filing history →

Source: SEC EDGAR

accession 0001213900-22-021397

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.